跳至主要内容
临床试验/NCT01399216
NCT01399216已完成不适用

Effects of a Supplement Containing Fucoidan as a Major Component on Basal Body Temperature: a Placebo Controlled, Cross-over Study

Hiroshima University1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2011年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
Basal body temperature

研究概览

简要总结

We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
55 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Postmenopausal women with basal body temperature < 36.0 ºC
  • •Healthy as based on medical history and physical examination
  • •Willing not to donate blood during the study
  • •Informed consent signed

排除标准

  • •Renal or hepatic dysfunction
  • •Heart disease
  • •Participation in any clinical trial within 90 days of the commencement of the trial
  • •Subjects who are taking medicines or functional food that may affect basal body temperature

研究组 & 干预措施

Fucoidan supplement

Experimental

干预措施: Supplement containing fucoidan, EPA, and DHA (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Basal body temperature

时间窗: up to 20 weeks

次要结局

  • Change from baseline in serum lipid levels (total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride)(Weeks 0, 8, 12, and 20)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fumiko Higashikawa

Associate Professor

Hiroshima University

研究点 (1)

Loading locations...

相似试验